Biochips Market worth $21.36 billion by 2030
The report "Biochips Market by Products & Services (Instruments, Software), Type (DNA Chips, Protein Chips, Lab-on-a-Chip), Application (High-throughput Screening, IVD, POC), Fabrication Technology (Microarrays, Microfluidics), & Region - Global Forecast to 2030", is projected to reach USD 21.36 billion by 2030 from USD 14.01 billion in 2025, at a CAGR of 8.8% during the forecast period.
Browse 300 market data Tables and 65 Figures spread through 350 Pages and in-depth TOC on "Biochips Market by Products & Services (Instruments, Software), Type (DNA Chips, Protein Chips, Lab-on-a-Chip), Application (High-throughput Screening, IVD, POC), Fabrication Technology (Microarrays, Microfluidics), & Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/biochips-advanced-technologies-and-global-market-54.html
The biochips market is witnessing strong growth, driven by demographic, economic, and technological factors. Rising demand for faster, more accurate, and cost-effective diagnostic and research tools is fueling adoption across genomics, proteomics, and drug discovery applications. Research institutions, pharmaceutical companies, and clinical laboratories are increasingly investing in microarrays and lab-on-chip systems to enhance precision, throughput, and data quality. Technological advancements such as AI integration, automation, and miniaturized microfluidic platforms are transforming workflows, enabling real-time analysis and decentralized testing. Additionally, the growing use of eco-friendly, disposable biochips and connected data management systems is improving accessibility, efficiency, and sustainability across the biochips ecosystem.
By type, the DNA Chips segment accounted for the largest market share in 2024.
In the biochips market, the DNA Chips segment accounted for the largest market share in 2024. This dominance is primarily due to their critical role in genomics research, diagnostics, and personalized medicine. These chips enable high-throughput analysis of gene expression, mutations, and genetic variations, making them essential for applications like disease detection, drug development, and genetic testing. Their widespread adoption in clinical diagnostics, coupled with ongoing advancements in microarray technology, has driven their dominance, as they provide a cost-effective and efficient solution for large-scale genetic analysis.
By fabrication technology, the microfluidics segment is expected to grow at the highest CAGR during the forecast period.
The microfluidics segment is expected to grow at the highest CAGR during the forecast period. The high CAGR can be attributed to its ability to handle small volumes of fluids with high precision, enabling cost-effective, rapid, and portable diagnostic solutions. By integrating multiple lab functions on a single chip, microfluidic devices reduce reagent consumption, speed up testing, and improve accessibility, particularly for point-of-care and field diagnostics. Advances in microfabrication techniques have made these systems more reliable and scalable, driving their adoption in applications like personalized medicine, environmental monitoring, and rapid pathogen detection.
By region, North America accounted for the largest share of the market in 2024.
In 2024, North America accounted for the largest share of the biochips market. This is attributed to its strong biotechnology and healthcare infrastructure, high investment in research and development, and a favorable regulatory environment. The presence of major biochip manufacturers, such as Thermo Fisher Scientific and Illumina, along with well-established academic and clinical research institutions, drives innovation and adoption. Additionally, the growing demand for precision medicine, personalized diagnostics, and point-of-care testing further boosts market growth in the region.
Key Market Players
The prominent players in the biochips market are Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN (Germany), Bio-Rad Laboratories, Inc. (US), Abbott (US), Standard BioTools Inc. (US), 10x Genomics (US), Cepheid (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Biochips Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
